S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
Would Buffett Approve of This Growth Strategy? (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
The Strategic Gold Play You Haven't Heard About (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
Would Buffett Approve of This Growth Strategy? (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
The Strategic Gold Play You Haven't Heard About (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
Would Buffett Approve of This Growth Strategy? (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
The Strategic Gold Play You Haven't Heard About (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
Would Buffett Approve of This Growth Strategy? (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
Would Buffett Approve of This Growth Strategy? (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
Target Will Close 9 Stores Across 4 States Due to Ongoing Crime That's 'Threatening the Safety' of Customers and Employees
The Strategic Gold Play You Haven't Heard About (Ad)
Video: Jack in the Box Employee Shoots at Customer Over Alleged Missing Curly Fries, Family Files Lawsuit
3 Mid-Cap Momentum Plays to Ride Into Q4
NASDAQ:ISEE

IVERIC bio (ISEE) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$39.95
$39.95
50-Day Range
$36.90
$39.95
52-Week Range
$9.39
$39.99
Volume
N/A
Average Volume
3.62 million shs
Market Capitalization
$5.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$25.75

IVERIC bio Short Interest Data

Current Short Volume
16,640,000 shares
Previous Short Volume
15,070,000 shares
Change Vs. Previous Month
+10.42%
Dollar Volume Sold Short
$639.48 million
Short Interest Ratio / Days to Cover
4.0
Last Record Date
June 15, 2023
Outstanding Shares
137,780,000 shares
Percentage of Shares Shorted
12.08%
Today's Trading Volume
0 shares
Average Trading Volume
3,616,141 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling IVERIC bio ?

Sign up to receive the latest short interest report for IVERIC bio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ISEE Short Interest Over Time

ISEE Days to Cover Over Time

ISEE Percentage of Float Shorted Over Time


IVERIC bio (NASDAQ:ISEE) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202316,640,000 shares $639.48 million +10.4%N/A4 $38.43
5/31/202315,070,000 shares $568.89 million +27.2%N/A4.1 $37.75
5/15/202311,850,000 shares $445.68 million +14.5%N/A3.2 $37.61
4/30/202310,350,000 shares $340.41 million -13.6%N/A2.8 $32.89
4/15/202311,980,000 shares $338.91 million +5.3%N/A4.8 $28.29
3/31/202311,380,000 shares $276.88 million +17.6%N/A4.7 $24.33
3/15/20239,680,000 shares $234.06 million -4.0%N/A4.1 $24.18
2/28/202310,080,000 shares $209.46 million +5.9%N/A4.1 $20.78
2/15/20239,520,000 shares $194.87 million -7.9%N/A4 $20.47
1/31/202310,340,000 shares $238.85 million -8.5%N/A4.3 $23.10
1/15/202311,300,000 shares $224.31 million +3.4%N/A4.4 $19.85
12/30/202210,930,000 shares $234.01 million +15.9%N/A4.1 $21.41
12/15/20229,430,000 shares $206.71 million +24.4%N/A3 $21.92
11/30/20227,580,000 shares $179.04 million -7.2%N/A2 $23.62
11/15/20228,170,000 shares $150.49 million -9.2%N/A1.3 $18.42
10/31/20229,000,000 shares $215.28 million +4.7%N/A1.5 $23.92
10/15/20228,600,000 shares $179.22 million +3.4%N/A1.5 $20.84
9/30/20228,320,000 shares $149.26 million -10.3%N/A1.4 $17.94
9/15/20229,280,000 shares $167.60 million +66.9%N/A1.7 $18.06
8/31/20225,560,000 shares $54.71 million -9.0%N/A1.1 $9.84
8/15/20226,110,000 shares $83.10 million -6.9%N/A3.2 $13.60
7/31/20226,560,000 shares $70.13 million -12.0%N/A3.1 $10.69
7/15/20227,450,000 shares $87.17 million -22.4%N/A3.6 $11.70
6/30/20229,600,000 shares $92.35 million +9.5%N/A4.8 $9.62
6/15/20228,770,000 shares $89.98 million +6.2%27.3%4.3 $10.26
5/31/20228,260,000 shares $86.23 million -6.5%N/A4.5 $10.44
5/15/20228,830,000 shares $92.63 million +17.9%N/A4.9 $10.49
4/30/20227,490,000 shares $103.74 million +7.3%N/A4.2 $13.85
4/15/20226,980,000 shares $120.89 million -3.5%N/A4.5 $17.32
3/31/20227,230,000 shares $121.68 million -4.0%N/A4.7 $16.83
3/15/20227,530,000 shares $108.21 million +0.1%N/A5.6 $14.37
2/28/20227,520,000 shares $120.62 million +1.5%N/A5.5 $16.04
2/15/20227,410,000 shares $113.60 million -1.9%N/A5.2 $15.33
1/31/20227,550,000 shares $105.25 million -45.4%N/A5.7 $13.94
1/15/202213,830,000 shares $189.06 million -1.8%N/A0 $13.67
12/31/202114,080,000 shares $235.42 million +1.4%N/A11.1 $16.72
12/15/202113,890,000 shares $213.49 million +5.2%N/A9.4 $15.37
11/30/202113,200,000 shares $192.98 million +8.5%N/A2.7 $14.62
11/15/202112,170,000 shares $200.68 million -5.0%N/A2.5 $16.49
10/29/202112,810,000 shares $226.74 million -0.1%N/A2.6 $17.70













ISEE Short Interest - Frequently Asked Questions

What is IVERIC bio's current short interest?

Short interest is the volume of IVERIC bio shares that have been sold short but have not yet been closed out or covered. As of June 15th, traders have sold 16,640,000 shares of ISEE short. Learn More on IVERIC bio's current short interest.

What is a good short interest ratio for IVERIC bio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ISEE shares currently have a short interest ratio of 4.0. Learn More on IVERIC bio's short interest ratio.

Which institutional investors are shorting IVERIC bio?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of IVERIC bio: Wolverine Trading LLC, Walleye Trading LLC, Westchester Capital Management LLC, Woodline Partners LP, Worth Venture Partners LLC, Goldman Sachs Group Inc., Polar Asset Management Partners Inc., Citadel Advisors LLC, Tudor Investment Corp Et Al, CSS LLC IL, Shay Capital LLC, Parallax Volatility Advisers L.P., Hunting Hill Global Capital LLC, Prelude Capital Management LLC, PEAK6 Investments LLC, Soros Fund Management LLC, Sand Grove Capital Management LLP, Citigroup Inc., BNP Paribas Arbitrage SNC, Wolverine Asset Management LLC, Simplex Trading LLC, Maven Securities LTD, Fifth Lane Capital LP, Picton Mahoney Asset Management, Harvest Management LLC, Equitec Proprietary Markets LLC, and FNY Investment Advisers LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is IVERIC bio's short interest increasing or decreasing?

IVERIC bio saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 16,640,000 shares, an increase of 10.4% from the previous total of 15,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does IVERIC bio's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to IVERIC bio: Zai Lab Limited (3.40%), Xenon Pharmaceuticals Inc. (4.32%), Inspire Medical Systems, Inc. (4.02%), Elanco Animal Health Incorporated (2.17%), Ascendis Pharma A/S (7.10%), BellRing Brands, Inc. (2.44%), Immunovant, Inc. (9.70%), The Ensign Group, Inc. (6.97%), Abcam plc (0.72%), Intra-Cellular Therapies, Inc. (2.32%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.80 billion), Canadian Natural Resources Limited ($3.69 billion), Charter Communications, Inc. ($2.95 billion), Occidental Petroleum Co. ($2.78 billion), Moderna, Inc. ($2.38 billion), Palantir Technologies Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.19 billion), Coinbase Global, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($2.02 billion), and Verisk Analytics, Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short IVERIC bio stock?

Short selling ISEE is an investing strategy that aims to generate trading profit from IVERIC bio as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against IVERIC bio?

A short squeeze for IVERIC bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ISEE, which in turn drives the price of the stock up even further.

How often is IVERIC bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ISEE, twice per month. The most recent reporting period available is June, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ISEE) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -